281 related articles for article (PubMed ID: 34048816)
1. Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation.
Van den Bosch L; van der Laan HP; van der Schaaf A; Oosting SF; Halmos GB; Witjes MJH; Oldehinkel E; Meijer TWH; van den Hoek JGM; Steenbakkers RJHM; Langendijk JA
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):456-467. PubMed ID: 34048816
[TBL] [Abstract][Full Text] [Related]
2. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis.
Havard M; Esslinger H; Mierzwa M; Kharofa J; Takiar V
Laryngoscope; 2021 Feb; 131(2):326-332. PubMed ID: 32609888
[TBL] [Abstract][Full Text] [Related]
3. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
Hammerlid E; Adnan A; Silander E
Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
5. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
7. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
8. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck Module, updated version: Preliminary psychometric data from Serbian laryngectomized patients.
Trivic SK; Trivic A; Singer S; Milovanovic J; Stankovic P; Mikic A; Vukasinovic M; Djordjevic V; Jotic A; Folic M; Stevanovic D
Head Neck; 2016 Apr; 38 Suppl 1():E916-24. PubMed ID: 26189891
[TBL] [Abstract][Full Text] [Related]
9. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
10. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
11. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E
Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926
[TBL] [Abstract][Full Text] [Related]
12. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
van der Laan HP; Van den Bosch L; Schuit E; Steenbakkers RJHM; van der Schaaf A; Langendijk JA
Radiother Oncol; 2021 Jul; 160():47-53. PubMed ID: 33892023
[TBL] [Abstract][Full Text] [Related]
13. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
[TBL] [Abstract][Full Text] [Related]
14. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM
PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.
Epstein JB; Robertson M; Emerton S; Phillips N; Stevenson-Moore P
Head Neck; 2001 May; 23(5):389-98. PubMed ID: 11295813
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study.
Bashir A; Kumar D; Dewan D; Sharma R
J Cancer Res Ther; 2020; 16(3):500-507. PubMed ID: 32719257
[TBL] [Abstract][Full Text] [Related]
17. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?
Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C
Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.
Bjordal K; Kaasa S; Mastekaasa A
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):847-56. PubMed ID: 8138437
[TBL] [Abstract][Full Text] [Related]
19. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
20. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]